RTS 28 BEST EXECUTION DISCLOSURE
Vintra Capital
RTS 28 BEST EXECUTION DISCLOSURE
YEAR TO 31 DECEMBER 2023
Introduction
Regulatory Technical Standard 28 requires Vintra Capital ( the Firm ) publishes on its website annually a review of its trade execution arrangements, covering the specific matters set forth under the headings below.
The Firm is a discretionary investment manager and may execute the decisions it makes to trade on behalf of its clients either directly on the execution venues set out in the Firm’s best execution policy, or via execution brokers who it selects for their ability to deliver “best execution” taking into account the execution factors that the Firm considers to be most important in the attainment of best execution.
Which instrument categories are covered by this report?
The Firm makes discretionary investment decisions for professional clients (unregulated and regulated fund vehicles). The strategies managed by the Firm utilise the following investments to deliver long term growth for clients:
Equities and Contracts for Difference s (CFD’s)
Unless otherwise stated, this report covers all of the instrument types above.
Importance of the relevant execution factors
The Firm’s investment strategy is global long short equity. The strategy is biased towards developed markets and analysable sectors with a focus on liquid, large or mid cap stocks. The Firm employs deep fundamental research to seek out individual long and short opportunities.
Consequently, the most important execution factors are price, size and nature of the order which influence the likelihood of execution, speed and costs.
These help to achieve best execution in the context of the investment strategy by Vintra Capital.
Close links, conflicts and common ownerships
The Firm has no “close links” (as defined by the Financial Conduct Authority), conflict or common ownerships with any execution venue or executing broker that it uses to execute its discretionary investment decisions made on behalf of clients.
Payments, discounts, rebates and non-monetary benefits
The Firm has not received any payments, discounts or non-monetary benefits from the trading venues or brokers used to execute trades on behalf of its clients.
Factors leading to a change in execution venues used
There have been no changes to the execution venues used during the period.
Do we view the execution factors differently depending on the client type?
All of the Firm’s clients are professional clients, either regulated and unregulated collective vehicles or individual managed accounts for individual professional investors. All investors are seeing access to the core strategy of the Firm as described above.
Changes to Execution Venues and Brokers
The Firm continually assesses the list of counterparties to ensure we obtain the best execution. There were no changes during 2020.
The Firm’s use of execution quality data/tools
The Firm uses Transaction Cost Analysis tools to assess execution quality. This system primarily considers implementation shortfall as well as highlighting outlying trades where costs deviated significantly from the pre-trade analysis.
The Firm’s use of consolidated tape providers
The Firm did not use any consolidated tape providers in determining “best execution” during the year.
Vintra Capital is satisfied that it has adhered to its best execution policy during 2020.
Quantitative Analysis
This disclosure if being made pursuant to Article 3(1) of RTS 28, which require firms to disclose, for each class of financial instruments traded during the period, the top venues or counterparties on/with which client orders were executed.
Class of Instrument | Equity Derivatives – Swaps and CFD | ||||
Notification if < 1 average trades per business day in the previous year | No | ||||
Top three execution venues ranked in terms of trading volumes (descending order) | Proportion of volume traded as a percentage of total in that class | Proportion of orders executed as a percentage of total in that class | Percentage of passive order | Percentage of aggressive orders | Percentage of directed orders |
UBS AG (BFM8T61CT2L1QCEMIK50) | 63.65% | 61.75% | - | - | 100% |
Goldman Sachs International (W22LROWP2IHZNBB6K528) | 32.78% | 35.26% | - | - | 100% |
Morgan Stanley & Co International Plc (4PQUHN3JPFGFNF3BB653) | 2.66% | 1.63% | - | - | 100% |